Royce & Associates LP Buys 9,152 Shares of Molina Healthcare, Inc $MOH

Royce & Associates LP increased its stake in shares of Molina Healthcare, Inc (NYSE:MOH) by 31.1% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 38,611 shares of the company’s stock after acquiring an additional 9,152 shares during the quarter. Royce & Associates LP owned approximately 0.07% of Molina Healthcare worth $7,389,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also bought and sold shares of the company. First Horizon Advisors Inc. boosted its stake in shares of Molina Healthcare by 2,140.0% during the second quarter. First Horizon Advisors Inc. now owns 112 shares of the company’s stock valued at $33,000 after purchasing an additional 107 shares during the period. Bogart Wealth LLC purchased a new position in shares of Molina Healthcare in the third quarter worth $39,000. CYBER HORNET ETFs LLC bought a new stake in Molina Healthcare during the 2nd quarter valued at $45,000. SJS Investment Consulting Inc. boosted its position in Molina Healthcare by 6,225.0% during the 3rd quarter. SJS Investment Consulting Inc. now owns 253 shares of the company’s stock valued at $48,000 after buying an additional 249 shares during the period. Finally, MUFG Securities EMEA plc purchased a new stake in Molina Healthcare during the 2nd quarter valued at $48,000. 98.50% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

MOH has been the topic of a number of analyst reports. Sanford C. Bernstein restated an “outperform” rating and issued a $224.00 price objective on shares of Molina Healthcare in a research report on Tuesday, January 6th. Wells Fargo & Company set a $141.00 target price on Molina Healthcare and gave the stock an “equal weight” rating in a research note on Friday, February 20th. UBS Group restated a “neutral” rating and set a $145.00 price target on shares of Molina Healthcare in a report on Monday, February 9th. Barclays dropped their price objective on Molina Healthcare from $164.00 to $133.00 and set an “underweight” rating for the company in a report on Tuesday, February 10th. Finally, Truist Financial reduced their target price on Molina Healthcare from $190.00 to $145.00 and set a “hold” rating on the stock in a research note on Tuesday, February 17th. Two equities research analysts have rated the stock with a Buy rating, ten have given a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, Molina Healthcare presently has an average rating of “Hold” and a consensus target price of $155.71.

Molina Healthcare Stock Performance

Molina Healthcare stock opened at $150.08 on Thursday. Molina Healthcare, Inc has a fifty-two week low of $121.06 and a fifty-two week high of $359.97. The stock has a market cap of $7.73 billion, a price-to-earnings ratio of 17.53 and a beta of 0.52. The stock’s 50 day simple moving average is $166.95 and its two-hundred day simple moving average is $168.43. The company has a debt-to-equity ratio of 0.97, a quick ratio of 1.69 and a current ratio of 1.69.

Molina Healthcare (NYSE:MOH) last released its earnings results on Thursday, February 5th. The company reported ($2.75) EPS for the quarter, missing analysts’ consensus estimates of $0.43 by ($3.18). The firm had revenue of $11.38 billion during the quarter, compared to analysts’ expectations of $10.90 billion. Molina Healthcare had a net margin of 1.04% and a return on equity of 13.60%. The company’s revenue for the quarter was up 8.3% compared to the same quarter last year. During the same quarter in the previous year, the business earned $5.05 EPS. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. As a group, analysts expect that Molina Healthcare, Inc will post 24.4 earnings per share for the current fiscal year.

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.